Comparison of Framingham Risk Score and Globorisk Cardiovascular Risk Prediction Models in Iranian Population

Cardiovascular disease is the leading cause of death in the world. The 10-year risk assessment of this illness is an essential step in managing future illness. This study aimed to compare Framingham Risk Score and Globorisk cardiovascular disease prediction models in the next ten years.

A descriptive cross-sectional study was performed using Mashhad's Electronic Health Record data with total cholesterol, high-density lipoprotein, smoking, blood pressure, and diabetes. The study population was people aged 30 years and older, with a sample of 161,828 people. T-test and chi-square tests were used to determine the relationship of dependence between the variables, and P-value less than 0.05 was considered.

The participants included 74.1% females. According to the Globorisk model, 67.2% of females and 79.9% of males were in the low-risk group, while in the Framingham model, this rate was 48.5% and 54.9%, respectively, in females and males. According to the Globorisk and Framingham model, 66.2% and 34.1% of people 70 years and older were high-risk. Both models also showed that people with diabetes and smokers are at higher risk for cardiovascular disease in the next ten years.

Considering the increased cardiovascular risk, it is necessary to use the capabilities of these models to assess the risk of disease in the next ten years and take measures to improve the community's general health and prevent cardiovascular events.